Cytokrom P450 gen-superfamiliens betydning for laegemidlers kliniske farmakokinetik.

K. Brøsen*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

It is presumed that there are between 20 and 200 medicamentoxidizing cytochrome P450 isozymes. The formation of every P450 isozyme is encoded by a separate gene and the P450 gene superfamily is classified into families and sub-families on the basis of the degree of amino acid relationship for the isozymes which are coded. The genetic polymorphism for 4-hydroxylation of the anti-epileptic preparation S-mephenytoin is associated with an isozyme in the P450IIC sub-family. In Denmark, approximately 3% of the population are poor metabolizers (PM) of mephenytoin. Mephenytoin polymorphism appears to be partially responsible for N-demethylation of diazepam and imipramine but the clinical significance of this is still obscure. Recent investigations suggest that conversion of proguanil to the active metabolite, cycloguanil, is reduced in mephenytoin-PM. The sparteine/debrisoquine-oxidation polymorphism is associated with P450IID6 isozyme and 7-8% of the Danish population are PM. The sparteine/debrisoquine polymorphism is of significance for elimination of more than 20 different medicaments with clinically significant consequences for tricyclic antidepressants, certain neuroleptic and certain antiarrhythmic drugs. P450IIIA4 is the third isozyme with demonstrated significance for elimination of clinically significant medicaments including cyclosporin A. No genetic polymorphism has, as yet, been demonstrated for this isozyme.

OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind153
Udgave nummer6
Sider (fra-til)417-422
Antal sider6
ISSN0041-5782
StatusUdgivet - 4. feb. 1991

Fingeraftryk

Cytochrome P-450 Enzyme System
Isoenzymes
Mephenytoin
Pharmacokinetics
Pharmaceutical Preparations
Debrisoquin
Genetic Polymorphisms
Proguanil
Imipramine
Denmark
Hydroxylation
Cyclosporine
Population
Amino Acids

Citer dette

@article{3f91babc12bb4a1794e41130d64b397c,
title = "Cytokrom P450 gen-superfamiliens betydning for laegemidlers kliniske farmakokinetik.",
abstract = "It is presumed that there are between 20 and 200 medicamentoxidizing cytochrome P450 isozymes. The formation of every P450 isozyme is encoded by a separate gene and the P450 gene superfamily is classified into families and sub-families on the basis of the degree of amino acid relationship for the isozymes which are coded. The genetic polymorphism for 4-hydroxylation of the anti-epileptic preparation S-mephenytoin is associated with an isozyme in the P450IIC sub-family. In Denmark, approximately 3{\%} of the population are poor metabolizers (PM) of mephenytoin. Mephenytoin polymorphism appears to be partially responsible for N-demethylation of diazepam and imipramine but the clinical significance of this is still obscure. Recent investigations suggest that conversion of proguanil to the active metabolite, cycloguanil, is reduced in mephenytoin-PM. The sparteine/debrisoquine-oxidation polymorphism is associated with P450IID6 isozyme and 7-8{\%} of the Danish population are PM. The sparteine/debrisoquine polymorphism is of significance for elimination of more than 20 different medicaments with clinically significant consequences for tricyclic antidepressants, certain neuroleptic and certain antiarrhythmic drugs. P450IIIA4 is the third isozyme with demonstrated significance for elimination of clinically significant medicaments including cyclosporin A. No genetic polymorphism has, as yet, been demonstrated for this isozyme.",
author = "K. Br{\o}sen",
year = "1991",
month = "2",
day = "4",
language = "Dansk",
volume = "153",
pages = "417--422",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "6",

}

Cytokrom P450 gen-superfamiliens betydning for laegemidlers kliniske farmakokinetik. / Brøsen, K.

I: Ugeskrift for Laeger, Bind 153, Nr. 6, 04.02.1991, s. 417-422.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - Cytokrom P450 gen-superfamiliens betydning for laegemidlers kliniske farmakokinetik.

AU - Brøsen, K.

PY - 1991/2/4

Y1 - 1991/2/4

N2 - It is presumed that there are between 20 and 200 medicamentoxidizing cytochrome P450 isozymes. The formation of every P450 isozyme is encoded by a separate gene and the P450 gene superfamily is classified into families and sub-families on the basis of the degree of amino acid relationship for the isozymes which are coded. The genetic polymorphism for 4-hydroxylation of the anti-epileptic preparation S-mephenytoin is associated with an isozyme in the P450IIC sub-family. In Denmark, approximately 3% of the population are poor metabolizers (PM) of mephenytoin. Mephenytoin polymorphism appears to be partially responsible for N-demethylation of diazepam and imipramine but the clinical significance of this is still obscure. Recent investigations suggest that conversion of proguanil to the active metabolite, cycloguanil, is reduced in mephenytoin-PM. The sparteine/debrisoquine-oxidation polymorphism is associated with P450IID6 isozyme and 7-8% of the Danish population are PM. The sparteine/debrisoquine polymorphism is of significance for elimination of more than 20 different medicaments with clinically significant consequences for tricyclic antidepressants, certain neuroleptic and certain antiarrhythmic drugs. P450IIIA4 is the third isozyme with demonstrated significance for elimination of clinically significant medicaments including cyclosporin A. No genetic polymorphism has, as yet, been demonstrated for this isozyme.

AB - It is presumed that there are between 20 and 200 medicamentoxidizing cytochrome P450 isozymes. The formation of every P450 isozyme is encoded by a separate gene and the P450 gene superfamily is classified into families and sub-families on the basis of the degree of amino acid relationship for the isozymes which are coded. The genetic polymorphism for 4-hydroxylation of the anti-epileptic preparation S-mephenytoin is associated with an isozyme in the P450IIC sub-family. In Denmark, approximately 3% of the population are poor metabolizers (PM) of mephenytoin. Mephenytoin polymorphism appears to be partially responsible for N-demethylation of diazepam and imipramine but the clinical significance of this is still obscure. Recent investigations suggest that conversion of proguanil to the active metabolite, cycloguanil, is reduced in mephenytoin-PM. The sparteine/debrisoquine-oxidation polymorphism is associated with P450IID6 isozyme and 7-8% of the Danish population are PM. The sparteine/debrisoquine polymorphism is of significance for elimination of more than 20 different medicaments with clinically significant consequences for tricyclic antidepressants, certain neuroleptic and certain antiarrhythmic drugs. P450IIIA4 is the third isozyme with demonstrated significance for elimination of clinically significant medicaments including cyclosporin A. No genetic polymorphism has, as yet, been demonstrated for this isozyme.

UR - http://www.scopus.com/inward/record.url?scp=18244412301&partnerID=8YFLogxK

M3 - Review

VL - 153

SP - 417

EP - 422

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 6

ER -